MedPath
NMPA Approval

Metformin Hydrochloride and Empagliflozin Tablets(Ⅵ)

国药准字H20249712

December 6, 2024

Drug Information

二甲双胍恩格列净片(Ⅵ)

片剂

每片含盐酸二甲双胍1000mg与恩格列净12.5mg

化学药品

December 6, 2024

Company Information

Applicant Company

重庆市经开区长生桥镇江峡路1号16幢(自编号4-6-3)

Manufacturing Company

重庆市荣昌区昌州街道板桥路143号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

二甲双胍恩格列净片(Ⅵ) - NMPA 批准文号 | MedPath